Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 140.00
-2.00 (-1.41%)
Aug 11, 2025, 1:30 PM CST
Lumosa Therapeutics Revenue
Lumosa Therapeutics had revenue of 2.18M TWD in the quarter ending June 30, 2025, a decrease of -74.40%. This brings the company's revenue in the last twelve months to 37.25M, down -21.93% year-over-year. In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M, down -31.21%.
Revenue (ttm)
37.25M
Revenue Growth
-21.93%
P/S Ratio
643.53
Revenue / Employee
866.30K
Employees
43
Market Cap
23.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.15M | -17.76M | -31.21% |
| Dec 31, 2023 | 56.92M | 30.27M | 113.63% |
| Dec 31, 2022 | 26.64M | 9.28M | 53.45% |
| Dec 31, 2021 | 17.36M | -4.29M | -19.81% |
| Dec 31, 2020 | 21.65M | -150.39M | -87.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |